Role of DNA methylation and folate metabolism in the development of pathological processes in the human body

Written by Shumatova T.A., Prikhodchenko N.G., Odenbakh L.A., Efremova I.V.

  Индекс УДК: 616‑057.7:577.213/.217 | Страницы: 39-43 | Полный текст статьи. PDF файл | Открыть PDF 


The review was devoted the current understanding of the role of DNA methylation in the physiology and pathology of the human body. It was revealed the influence of genotype on epigenotype, the factors that trigger and suppress the processes of DNA methylation and histone deacetylation, the role of the state of folate metabolism in the development of pathological processes. Special attention was paid to the role of genes encoding enzymes of folate cycle, since lack of methyl groups directly linked to polymorphisms in these genes. It was shown that poly‑morphic variants of genes MTHFR, MTRR and MTR, causing different functional significance of protein products affect a wide range of biochemical reactions in the folate cycle, and, according to some authors, can be regarded as a risk factor for a number of diseases.

Ссылки на авторов:

T.A. Shumatova, N.G. Prikhodchenko, L.A. Odenbakh, I.V. Efremova
Pacific State Medical University (2 Ostryakova Av. Vladivostok 690950 Russian Federation)

  1. Vanyushin B.F. DNA methylation and epigenetics // Genetics. 2006. Vol. 42, No. 9. P. 1186–1199.
  2. Golyshev S.A., Vikhreva P.N., Sheval E.V. [et al.] Role of DNA methylation and post‑translational modifications of histones in maintaining and arranging the structure of heterochromatin domains (chromocenters) // Cytology. 2008. Vol. 50, No. 11. P. 972–982.
  3. Grechanina E.Ya., Matalon R., Grechanina Yu.B. [et al.] Hereditary metabolic disorders in sulfur aminoacids // Russian bulletin of perinatology and pediatrics. 2009. No. 54. P. 53–61.
  4. Kozlov V.A. Methylation of DNA cell and organism’s pathology // Medical immunology. 2008. Vol. 10, No. 4–5. P. 307–318.
  5. Lebedev I.N., Sazhenova E.A. Epimutations of imprinted genes in the human genome: classifications, etiology, relations with hereditary disease // Genetics. 2008. Vol. 44, No. 10. P. 1356–1373.
  6. Fetisova I.N., Dobrolyubov A.S., Lipin M.A. [et al.] Polymorphism in genes of folate metabolism and human disease // Bulletin of new medical technologies.2007. Vol. X, No. 1. P. 23–28.
  7. Yurov I.Yu., Vorsanova S.G., Voinova‑Ulas V.Yu. [et al.] Epigenetic studies of Rett syndrome as an adequate model of autistic disorders // S.S. Korsakov’s Journal of Neurology and Psychiatry. 2005. Vol. 105, No. 7. P. 4–11.
  8. Yurov I.Yu., Villard L., Vorsanova S.G. [et al.] Features of X chromosome inactivation in women over the age of 70 // Cytology and genetics. 2004. Vol. 4.P. 49–54.
  9. Balada E., Ordi‑Ros J., Serrano‑Acedo S. [et al.] Transcript overexpression of the MBD2 and MBD4 genes in CD4+ T cells from systemic lupus erythematosus patients // J. Leukoc. Biol. 2007. Vol. 81, No. 6. P. 1609–1619.
  10. Bird A. DNA methylation patterns and epigenetic memory // Genes Dev. 2002. Vol. 16. P. 6–21.
  11. Blom H.J., Shaw G.M., Finnell R.H. Neural tube defects and folate: case far from closed // Nat. Rev. Neurosci. 2006. Vol. 7. P. 724–731.
  12. Bruce K.D., Cagampang F.R. Epigenetic priming of the metabolic syndrome // Toxicol. Mech. Methods. 2011. Vol. 21, No. 4. P. 353–361.
  13. Castel S.E., Martienssen R.A. RNA interference in the nucleus: roles for small RNAs in transcription, epigenetics and beyond // Nat. Rev. Genet. 2013. Vol. 14, No. 2. P. 100–112.
  14. Craig J.M. Heterochromatin ‑ many flavours, common themes // Bioessays. 2004. Vol. 27. P. 17–28.
  15. Crider K.S., Yang T.P., Berry R.J., Bailey L.B. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate’s role // Adv. Nutr. 2012 . Vol. 3, No. 1. P. 21–38.
  16. Feltus F.A., Lee E.K., Costello J.F. [et al.] Predicting aberrant CpG island methylation // PNAS. 2003. Vol. 100, No. 21. P. 12253–12258.
  17. Grechanina E., Matalon R.K., Holmse B.B. Genetic Polymorphisms of Methylenetetrahydrofolate Reductase (MTHFR), Methionine Synthase Reductase (MTRR), and Reduced Folate Carrier‑1 (RFC‑1) in a High Neural Tube Defect Risk Population // J. Inherit. Metab. Dis. 2007. Vol. 30, No. 1. P. 30.
  18. Herrmann W., Lorenzl S., Obeid R. Review of the role of hyperhomocysteinemia and B‑vitamin deficiency in neurological and psychiatric disorders‑‑current evidence and preliminary recommendations // Fortschr Neurol Psychiatr. 2007. Vol. 75, No. 9. P. 515–527.
  19. Hogg K., Price E.M., Hanna C.W., Robinson W.P. Prenatal and perinatal environmental influences on the human fetal and placental epigenome // Clin. Pharmacol. Ther. 2012. Vol. 92, No. 6. P. 716–726.
  20. Kankirawatana P., Leonard H., Ellaway C. [et al.] Early progressive encephalopathy in boys and MECP2 mutations // Neurology. 2006. Vol. 67, No. 1. P. 164–166.
  21. Kellermayer R. Epigenetics and the developmental origins of inflammatory bowel disease // Canadian J. Gastroenterol. 2012. Vol. 26, No. 12. P. 909–915.
  22. Lee W.J., Kim H.J. Inhibition of DNA methylation is involved in transdifferentiation of myoblasts into smooth muscle cells // Mol. Cells. 2007. Vol. 24, No. 3. P. 441–444.
  23. Miltenberger‑Miltenyi G., Laccone F. Mutations and polymorphisms in the human methyl CpG‑binding protein MECP2 // Hum. Mutat. 2003. Vol. 22, No. 2. P. 107–115.
  24. Moog U., Smeets E.E., van Roozendaal K.E. [et al.] Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2) // Europ. J. Paediat. Neurol. 2003. Vol. 7. P. 5–12.
  25. Müller T., Jugel C., Muhlack S. [et al.] Methyl group‑donating vitamins elevate 3‑o‑methyldopa in patients with Parkinson disease // Clin Neuropharmacol. 2013. Vol. 36, No. 2. P. 52–54.
  26. Rodenhiser D., Mann M. Epigenetics and human disease: translating basic biology into clinical application // CMAJ. 2006. Vol. 174, No. 3. P. 341–348.
  27. Sabbagh A.S., Mahfoud Z. High Prevalence of MTHFR Gene A1298C Polymorphism in Lebanon // Genetic Testing. 2008. Vol. 12, No. 1. P. 75–80.
  28. Scarano M.I., Strazzullo M., Matarazzo R. DNA methylation 40 years later: its role in human health and disease // J. Cell. Physiol. 2005. Vol. 204, No. 1. P. 21–35.
  29. Sharp L., Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: A HuGE Review // Am. J. Epidemiol. 2004. Vol. 159. Р. 423–443.
  30. Shibata K.R., Aoyama T., Shima Y. [et al.] Expression of the p161NK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion // Stem. Cells. 2007. Vol. 25, No. 9. P. 2371–2382.
  31. Tadokoro Y., Ema H., Okano M. [et al.] De novo DNA methyltransferase is essential for self‑reneval, but not for differentiation, in hematopoietic stem cells // J. Exp. Med. 2007. Vol. 204, No. 4. P. 715–722.
  32. Topcu M., Akyerli C., Sayi A. [et al.] Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy // Europ. J. Hum. Genet. 2002. Vol. 10. P. 77–81.
  33. Vivekanandan P., Thomas D., Torbenson M. Hepatitis B viral DNA is methylated in liver tissues // J. Viral. Hepat. 2008. Vol. 15, No. 2. P. 103–107.
  34. Vliet J., Oates N.A., Whitelaw. Epigenetic mechanisms in context in the complex diseases // Cell. Mol. Life Sci. 2007. Vol. 64. P. 1531–1538.
  35. Vogel S., Meyer K., Fredriksen A. [et al.] Serum folate and vitamin B12 concentrations in relation to prostate cancer risk – a Norwegian population‑based nested case‑control study of 3000 cases and 3000 controls within the JANUS cohort // Int. J. Epidemiol. 2013. Vol. 42, No. 1. P. 201–210.
  36. Waggoner D. Mechanisms of disease: epigenesist // Semin. Pediatr. Neurol. 2007. Vol. 14. P. 7–14.
  37. Weaving L.S., Williamson S.L., Bennetts B. [et al.] Effects of MECP2 mutation type, location and X‑inactivation in modulating Rett syndrome phenotype // Am. J. Med. Genet. 2003. Vol. 118A. P. 103–114.
  38. Yang I.V., Schwartz D.A. Epigenetic mechanisms and the development of asthma // J. Allergy Clin. Immunol. 2012. Vol. 130, No. 6. P. 1243–1255.


Founded in 1997  |  Editions in a year: 4, Articles in one issue: 30 |  ISSN of print version: 1609-1175  |  Ind.: 18410 (Agency "Rospechat’")  |  Edition: 1000 c.